http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102552180-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b26e17432236aa949f62b08733832285
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d21fe69e4b4d54ab02481a32a57bde08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e70120a8264438e4c447956def4207fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c394a8997453554ebaf4a3496267e976
publicationDate 2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102552180-B
titleOfInvention Clindamycin phosphate composition liensinine freeze-dried powder and preparation method thereof
abstract The invention relates to the technical field of medicines, and discloses clindamycin phosphate composition liensinine freeze-dried powder and a preparation method thereof. The clindamycin phosphate composition liensinine freeze-dried powder is prepared from the following raw materials in part by weight: 300 parts of clindamycin phosphate, 0.4 part of disodium edetate, 0.3 part of sodium hydrogensulfite and 0.025 part of sorbierite, wherein the sorbierite can be used as a medicinal dispersing agent to improve the solubility of medicines, and also can enhance an antibacterial effect of the clindamycin phosphate. The clindamycin phosphate composition liensinine freeze-dried powder enhances the antibacterial effect, is high in stability, and can be widely used for treating bacterial infection diseases such as respiratory tract infection, bone and joint infection, pelvic infection, abdominal infection and the like.
priorityDate 2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71511309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447700863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16052039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160644
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506553
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449013851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415857703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428420230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426221723

Total number of triples: 50.